CLOVIS ONCOLOGY INC - NOTE 2.500% 9/1

CUSIP: 189464AB6

Q4 2017 13F Holders as of 31 Dec 2017

Type / Class
Debt / NOTE 2.500% 9/1
Market price (% of par)
135.0%
Total 13F principal
$251,632,005
Principal change
+$3,059,996
Total reported market value
$339,143,007
Number of holders
27
Value change
-$3,649,740
Number of buys
19
Number of sells
9

Quarterly Holders Quick Answers

What is CUSIP 189464AB6?
CUSIP 189464AB6 identifies 189464AB6 - CLOVIS ONCOLOGY INC - NOTE 2.500% 9/1 in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Institutional Holders of CLOVIS ONCOLOGY INC - NOTE 2.500% 9/1 as of Q4 2017

As of 31 Dec 2017, CLOVIS ONCOLOGY INC - NOTE 2.500% 9/1 was held by 27 institutional bondholders reporting positions in Form 13F filings. These institutions reported holding $251,632,005 in principal (par value) of the bond. The largest 10 bondholders included Linden Advisors LP, D. E. Shaw & Co., Inc., Allianz Asset Management GmbH, CAPSTONE INVESTMENT ADVISORS, LLC, BANK OF AMERICA CORP /DE/, ZAZOVE ASSOCIATES LLC, CREDIT SUISSE AG/, AMERIPRISE FINANCIAL INC, ADVENT CAPITAL MANAGEMENT /DE/, and CSS LLC/IL. This page lists 27 institutional bondholders reporting positions for the Q4 2017 filing period.
Investor Option Weight % Change % Value $ * Price (% of par) Principal Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.